Sign in
4

Changes in Ownership

Perspective Therapeutics, Inc. Filed Acc 0001437749-18-012097

Options or other derivatives

  • Interim CEO acquired 250,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Derivatives
Woods Lori A Interim CEO 2018-06-13 Grant or award · Stock Options (right to buy) +250,000 350,000 D
Loading xslF345X03/rdgdoc.xml…